JPRN-UMIN000016518尚未招募未知
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancer - A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancer
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Previous history of severe drug-induced allergy 2.Multiple malignancies to be treated or synchronous colorectal cancer 3. Active infections 4. Serious complications 5.Previous history of Interstitial Pneumonitis 6.Pleural effusion or ascites requiring treatment. 7. Active digestive tract bleeding 8. Severe watery diarrhea 9. Pregnant or nursing 10.Systemic administration of corticosteroids 11. Patients of hepatitis B virus suface antigen positivity 12.Contraindication of S-1or CPT-11 13. Patients judged inappropriate for this study by the physicians
研究者
相似试验
已完成
2 期
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage IB2,IIA2 orIIB uterine cervical cancer SGSG014Cervical cancer patients with clinical stage IB2, IIA, IIBJPRN-UMIN000009643Sankai Gynecology Study Group50
已完成
不适用
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage Ib2-IIb uterine cervical cancer (SGSG013)JPRN-UMIN000006440Sankai Gynecology Study Group50
已完成
2 期
Phase II Trial of Preoperative Chemotherapy and Bevacizumab in Patients With Stage IIIA Non-Squamous Non-Small Cell Lung Canceron-squamous, Non-small cell lung cancerJPRN-UMIN000004487Osaka International Cancer Institute30
已完成
不适用
A phase II study of preoperative chemotherapy cosisting docetaxel, oxaliplatin and S-1 for the clinical Stage III gastric cancerGastric cancerJPRN-UMIN000017652Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine50
招募中
2 期
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50